All In Biotech

Free tool

FAERS Monitor: Monistat 3 Combination Pack

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020670 or its brand name (Monistat 3 Combination Pack, Miconazole Nitrate). Reports on generic versions are filed under their own applications.

Reports

5,389

Serious

994

18% of reports

Hospitalization

357

Death reported

91

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vulvovaginal burning sensation1,784
  • drug ineffective998
  • vulvovaginal pain945
  • vulvovaginal pruritus572
  • condition aggravated498
  • vulvovaginal discomfort440
  • vaginal haemorrhage415
  • vulvovaginal swelling306
  • pain155
  • hypersensitivity141
  • burning sensation136
  • pruritus132
  • vaginal discharge122
  • off label use113
  • abdominal pain112

Reports by year received

View as table
YearReports
200423
200524
200627
200721
200848
200976
201054
201159
201283
201327
201438
201546
2016473
2017428
2018516
2019416
2020461
2021517
2022376
2023290
2024416
2025456
2026514

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,770 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vulvovaginal burning sensationSignal1,7841610.71534.92,031,468
vulvovaginal painSignal945952.0891.3721,242
vulvovaginal swellingSignal306785.3696.6198,927
vulvovaginal pruritusSignal572496.7457.2250,666
vulvovaginal discomfortSignal440431.4392.4169,783
vaginal dischargeSignal12247.639.95,456
vaginal haemorrhageSignal41537.734.314,664
burning sensationSignal1367.66.4772
condition aggravatedSignal4986.45.92,294
hypersensitivitySignal1413.02.5183
drug ineffectiveSignal9983.02.81,376
abdominal pain1121.91.646
pruritus1321.31.111
pain1551.00.80
off label use1130.50.457

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.